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Background: Gastroschisis is a congenital malformation char-
acterized by the extrusion of the fetal bowel during intrauterine
life, secondary to a defect in anterior abdominal wall. Objective:
To establish an experimental model of gastroschisis in fetuses
of rats exposed to acetylsalicylic acid (ASA), during pregnancy.
Methods: Wistar rats were treated with an oral single ASA dose
of 50, 500, 750 or 1000 mg/kg of maternal body weight on 6th,
9th or 12th days of gestation; with distilled water (group sham)
and no treated (group control). It was evaluated the number of
live, dead and reabsorbed fetuses, the weight and length of the
fetuses and identified individuals with external malformations.
Results: At dose of 500 mg was observed incidence of 18.3% of
gastroschisis while at 1000 mg dose this value was 31.6%, dem-
onstrating that increasing the dose causes an increase in the
teratogenic potential of ASA. The dose of 50 mg, which repro-
duces the pharmacological effect in humans, was related to
the occurrence of omphalocele in 7 fetuses. The 750 mg group
had more fetuses reabsorbed; all groups with ASA had more
omphalocele than sham and control groups. Only the group
of 1000 mg on the 12th day of pregnancy had polydactyly;
groups with 500 and 1000 mg had more gastroschisis. Conclu-
sions: There was a predominance of abnormalities in the wall
defect (gastroschisis and omphalocele) and present at all doses
of ASA administered. The higher doses than the physiological
dose showed other malformations described in a few previous
studies, as polydactyly.
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Neural tube defects (NTDs) are the second commonest group
of birth defects in humans. Included among the NTDs are spina
bifida and exencephaly. Different lines of evidence suggest a
likely role for protein acetylation status in the aetiology of NTDs.
First, valproic acid (VPA), a well-known teratogen that induces
NTDs in both humans and animal models, is capable of disrupt-
ing the acetylation equilibrium in target embryonic tissues. Sec-
ond, genetic mutations in mice that result in altered acetylation
activity also cause NTDs. HAT (histone acetyltransferase)
enzymes act primarily on histones, but can also acetylate a num-
ber of other proteins, including p53. Embryos homozygous for a
point mutation in the catalytic domain of the HAT enzyme Gcn5
show severe NTDs, while mice null for Cited2, which binds to
the HAT p300/CBP, develop anencephaly. These results indicate
a requirement for regulation of acetyltransferase activity in order
for the neural tube to close successfully. In the present study, we
evaluated acetylation status of proteins during neural tube clo-
sure, with a specific focus on alteration of p53 acetylation as a
potential mechanism underlying development of NTDs. We show
a dynamic pattern of overall protein acetylation in neurulation-
stage embryos, and detect differentially acetylated proteins in
Cited2 mutant embryos compared to wild-type. We also identify
an increased level of acetylated-p53 in Cited2 null embryos. Our
preliminary findings suggest that inducing p53 degradation res-
cues exencephaly in Cited2 null embryos. Acetylation status of
p53 may be a key factor determining risk of defective neural tube
closure in mammals.
doi:10.1016/j.mod.2009.06.282
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